| Catalog No. |
Size |
Price |
Figures |
|---|
Z00135-1 mg
| 1 mg | $ 420.00 |
References:
- Maillard P, Krawczynski K et al. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol. Sep 2001;75(17):8240-50.
|
|---|
| Full Name | | Hepatitis C Virus (HCV) Nucleocapsid Genotype 4 |
|
| Abbreviated Name-1 | Hepatitis NG4; HCV NG4 |
|---|
| Abbreviated Name-2 | rHCVNG4 |
|---|
| Description | E. coli derived recombinant. The protein Hepatitis C Virus (HCV) Nucleocapsid Genotype 4 contains the HCV core immunodominant region. |
|---|
| Source | E. coli |
|---|
| Purity | Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 25 mM Tris-Hcl pH8, 1 mM EDTA, 1.5 M urea, 50% glycerol. |
|---|
| Stability | Five years frozen. One month in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of HCV-infected individuals, including sera with antibodies to NS3 secondary domains. |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems. |
|---|
